二丙酸倍氯米松与口咽念珠菌病
Beclomethasone dipropionate and oropharyngeal candidiasis.
作者信息
Milne L J, Crompton G K
出版信息
Br Med J. 1974 Sep 28;3(5934):797-8. doi: 10.1136/bmj.3.5934.797.
Abstract
A survey of 936 patients attending a respiratory diseases unit outpatient department was performed to assess the incidence of oropharyngeal candidiasis in patients inhaling beclomethasone dipropionate in daily doses of 400 mug or less. Throat swabs from 209 (41%) patients treated with beclomethasone were positive on culture for yeasts compared with positive swabs from 77 (27.2%) patients not receiving corticosteroid therapy either orally or by inhalation. Clinical oropharyngeal thrush, confirmed by culture, was detected in 28 (5.5%) patients inhaling beclomethasone, one (0.7%) patient receiving treatment with oral prednisolone, and two (0.7%) patients not being treated with corticosteroids.
摘要
对936名呼吸疾病科门诊患者进行了一项调查，以评估每日吸入丙酸倍氯米松剂量为400微克或更低的患者中口咽念珠菌病的发病率。接受丙酸倍氯米松治疗的209名（41%）患者的咽拭子培养出酵母呈阳性，相比之下，未接受口服或吸入皮质类固醇治疗的77名（27.2%）患者的咽拭子培养也呈阳性。经培养确诊的临床口咽念珠菌病在28名（5.5%）吸入丙酸倍氯米松的患者、1名（0.7%）接受口服泼尼松龙治疗的患者和2名（0.7%）未接受皮质类固醇治疗的患者中被检测到。
相似文献
1
Beclomethasone dipropionate and oropharyngeal candidiasis.二丙酸倍氯米松与口咽念珠菌病
Br Med J. 1974 Sep 28;3(5934):797-8. doi: 10.1136/bmj.3.5934.797.
2
Beclomethasone dipropionate aerosol and oropharyngeal candidiasis.丙酸倍氯米松气雾剂与口咽念珠菌病
Br J Dis Chest. 1976 Jan;70(1):32-8. doi: 10.1016/0007-0971(76)90004-8.
3
Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone.吸入性糖皮质激素使用相关的口腔念珠菌病：氟替卡松与倍氯米松的比较
Ann Allergy Asthma Immunol. 2003 Jun;90(6):646-51. doi: 10.1016/S1081-1206(10)61870-4.
4
Letter: Beclomethasone aerosol in chronic bronchial asthma.信函：倍氯米松气雾剂用于慢性支气管哮喘
Lancet. 1974 Oct 5;2(7884):838. doi: 10.1016/s0140-6736(74)91098-8.
5
Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Preliminary report of the Brompton Hospital-Medical Research Council Collaborative Trial.比较二丙酸倍氯米松气雾剂两种给药方案治疗慢性支气管哮喘的双盲试验。布朗普顿医院 - 医学研究理事会合作试验的初步报告。
Lancet. 1974 Aug 10;2(7876):303-7.
6
Indications for use of beclomethasone dipropionate (Vanceril).二丙酸倍氯米松（必可酮）的使用指征。
West J Med. 1979 Oct;131(4):314-5.
7
Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma.二丙酸倍氯米松吸入器：其药理学、治疗价值及不良反应综述。I：哮喘
Drugs. 1975;10(3):166-210. doi: 10.2165/00003495-197510030-00002.
8
Asthma--treatment with the aerosol steroid beclomethasone dipropionate.
Ann Allergy. 1974 Sep;33(3):150-4.
9
Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol with a placebo in chronic bronchial asthma. Second report of the Brompton Hospital/Medical Research Council Collaborative Trial.丙酸倍氯米松气雾剂两种给药方案与安慰剂治疗慢性支气管哮喘的双盲试验。布朗普顿医院/医学研究理事会协作试验的第二份报告。
Br J Dis Chest. 1979 Apr;73(2):121-32.
10
Letter: Steroid aerosols and candidiasis.信件：类固醇气雾剂与念珠菌病。
Br Med J. 1974 May 18;2(5915):387. doi: 10.1136/bmj.2.5915.387-b.
引用本文的文献
1
Non-Pharmacological Interventions to Prevent Oropharyngeal Candidiasis in Patients Using Inhaled Corticosteroids: A Narrative Review.预防吸入性糖皮质激素使用者发生口咽念珠菌病的非药物干预措施：一项叙述性综述
Healthcare (Basel). 2025 Jul 17;13(14):1718. doi: 10.3390/healthcare13141718.
2
Posterior pharyngeal candidiasis in the absence of clinically overt oral involvement: a cross-sectional study.后咽部假丝酵母菌病在无明显口腔受累的情况下：一项横断面研究。
Lung. 2013 Dec;191(6):663-8. doi: 10.1007/s00408-013-9503-3. Epub 2013 Sep 13.
3
Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis.吸入性皮质类固醇与口腔念珠菌病的发生：处方序列对称分析。
Drug Saf. 2013 Apr;36(4):231-6. doi: 10.1007/s40264-013-0029-7.
4
Oral candidiasis.口腔念珠菌病
Postgrad Med J. 2002 Aug;78(922):455-9. doi: 10.1136/pmj.78.922.455.
5
Large volume spacer devices and the influence of high dose beclomethasone dipropionate on hypothalamo-pituitary-adrenal axis function.大容量储雾罐装置及高剂量二丙酸倍氯米松对下丘脑-垂体-肾上腺轴功能的影响
Thorax. 1993 Mar;48(3):233-8. doi: 10.1136/thx.48.3.233.
6
Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality.吸入性类固醇引起的发声障碍：一种特征性喉部异常的识别。
Thorax. 1983 Nov;38(11):813-21. doi: 10.1136/thx.38.11.813.
7
Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis.二丙酸倍氯米松。在用于哮喘和鼻炎十年后对其药效学特性和治疗效果的重新评估。
Drugs. 1984 Aug;28(2):99-126. doi: 10.2165/00003495-198428020-00002.
8
Inhaled beclomethasone and oral candidiasis.吸入性倍氯米松与口腔念珠菌病。
Arch Dis Child. 1986 Aug;61(8):788-90. doi: 10.1136/adc.61.8.788.
9
Adverse effects of inhaled corticosteroids.吸入性糖皮质激素的不良反应。
BMJ. 1989 Feb 18;298(6671):403-4. doi: 10.1136/bmj.298.6671.403.
10
Inhaled corticosteroids: benefits and risks.吸入性糖皮质激素：益处与风险。
Thorax. 1992 Jun;47(6):404-7. doi: 10.1136/thx.47.6.404.
本文引用的文献
1
Incidence of candida in hospital in-patients and the effects of antibiotic therapy.医院住院患者念珠菌感染率及抗生素治疗的影响。
Br Med J. 1966 Jan 22;1(5481):208-10. doi: 10.1136/bmj.1.5481.208.
2
Beclomethasone dipropionate by inhalation in the treatment of airways obstruction.吸入丙酸倍氯米松治疗气道阻塞
Br J Dis Chest. 1972 Apr;66(2):101-6.
3
Steroid aerosols in asthma: an assessment of betamethasone valerate and a 12-month study of patients on maintenance treatment.哮喘治疗中的类固醇气雾剂：戊酸倍他米松评估及对维持治疗患者的12个月研究
Br Med J. 1974 Feb 2;1(5900):171-5. doi: 10.1136/bmj.1.5900.171.
4
A controlled trial of beclomethasone dipropionate for asthma.
Br J Dis Chest. 1973 Jul;67(3):208-14. doi: 10.1016/0007-0971(73)90055-7.
5
Beclomethasone dipropionate steriod aerosol in treatment of perennial allergic asthma in children.丙酸倍氯米松气雾剂治疗儿童常年性过敏性哮喘
Br Med J. 1973 Jul 21;3(5872):161-4. doi: 10.1136/bmj.3.5872.161.
Zotero 插件